Market Overview – In 2022, the market for vasomotor symptoms was estimated to be worth USD 3.5 billion. The market for vasomotor symptoms is expected to expand at a compound annual growth rate (CAGR) of 6.90% between 2023 and 2030, from an estimated USD 3.74 billion in 2023 to USD 5.58 billion by 2030. The Vasomotor Symptoms (VMS) market is evolving, with a focus on innovative treatments...